Umecrine Cognition AB Completes Last Patient Follow-Up in PBC Phase 1b/2a
Umecrine Cognition AB said the final patient follow-up is complete in its randomized, placebo-controlled Phase 1b/2a PBC study of golexanolone; results are expected early November 2026.Material DetailsContext by AI AnalystThis marks an operational milestone ahead of a near-term efficacy readout in…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.